Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
6,982
archived clinical trials in
Endocrine

Role of Growth Hormone Antagonism in Modulating Insulin Sensitivity in Subjects With Pre-diabetes
Role of Growth Hormone Antagonism in Modulating Insulin Sensitivity in Subjects With Insulin Resistance But Without Diabetes
Status: Enrolling
Updated:  7/15/2015
San Francisco General Hospital
mi
from
San Francisco, CA
Role of Growth Hormone Antagonism in Modulating Insulin Sensitivity in Subjects With Pre-diabetes
Role of Growth Hormone Antagonism in Modulating Insulin Sensitivity in Subjects With Insulin Resistance But Without Diabetes
Status: Enrolling
Updated: 7/15/2015
San Francisco General Hospital
mi
from
San Francisco, CA
Click here to add this to my saved trials
Pharmacokinetic Study of Testosterone
An Open-Label Study to Evaluate the Pharmacokinetics of Testosterone After Single-Dose Injection Via QuickShot® Testosterone in Healthy Male Subjects
Status: Enrolling
Updated:  7/20/2015
Medpace Clinical Pharmacology Unit
mi
from
Cincinnati, OH
Pharmacokinetic Study of Testosterone
An Open-Label Study to Evaluate the Pharmacokinetics of Testosterone After Single-Dose Injection Via QuickShot® Testosterone in Healthy Male Subjects
Status: Enrolling
Updated: 7/20/2015
Medpace Clinical Pharmacology Unit
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Med Diet Prevention Metabolic Syndrome Men Undergoing Androgen Deprivation Therapy Prostate Cancer
Eight Week Plant-based Mediterranean Diet as Prevention of Metabolic Syndrome in Men Undergoing Androgen Deprivation Therapy for Prostate Cancer: A BrUOG Pilot Study
Status: Enrolling
Updated:  7/21/2015
Miriam Hospital
mi
from
Providence, RI
Med Diet Prevention Metabolic Syndrome Men Undergoing Androgen Deprivation Therapy Prostate Cancer
Eight Week Plant-based Mediterranean Diet as Prevention of Metabolic Syndrome in Men Undergoing Androgen Deprivation Therapy for Prostate Cancer: A BrUOG Pilot Study
Status: Enrolling
Updated: 7/21/2015
Miriam Hospital
mi
from
Providence, RI
Click here to add this to my saved trials
To Evaluate Sperm Parameters in Men With Secondary Hypogonadism Previously Treated With Topical Testosterone
A Randomized, Open-Label, Fixed Dose, Active-Control, Multi-Center Phase IIB Study to Evaluate Fertility in Men With Secondary Hypogonadism, Comparing Androxal® to a Topical Testosterone in Men Previously Treated With Topical Testosterone.
Status: Enrolling
Updated:  7/22/2015
University Urology Associates
mi
from
New York, NY
To Evaluate Sperm Parameters in Men With Secondary Hypogonadism Previously Treated With Topical Testosterone
A Randomized, Open-Label, Fixed Dose, Active-Control, Multi-Center Phase IIB Study to Evaluate Fertility in Men With Secondary Hypogonadism, Comparing Androxal® to a Topical Testosterone in Men Previously Treated With Topical Testosterone.
Status: Enrolling
Updated: 7/22/2015
University Urology Associates
mi
from
New York, NY
Click here to add this to my saved trials
To Evaluate Sperm Parameters in Men With Secondary Hypogonadism Previously Treated With Topical Testosterone
A Randomized, Open-Label, Fixed Dose, Active-Control, Multi-Center Phase IIB Study to Evaluate Fertility in Men With Secondary Hypogonadism, Comparing Androxal® to a Topical Testosterone in Men Previously Treated With Topical Testosterone.
Status: Enrolling
Updated:  7/22/2015
MAZE Labs
mi
from
Purchase, NY
To Evaluate Sperm Parameters in Men With Secondary Hypogonadism Previously Treated With Topical Testosterone
A Randomized, Open-Label, Fixed Dose, Active-Control, Multi-Center Phase IIB Study to Evaluate Fertility in Men With Secondary Hypogonadism, Comparing Androxal® to a Topical Testosterone in Men Previously Treated With Topical Testosterone.
Status: Enrolling
Updated: 7/22/2015
MAZE Labs
mi
from
Purchase, NY
Click here to add this to my saved trials
Xanthohumol and Metabolic Syndrome
Xanthohumol and Metabolic Syndrome
Status: Enrolling
Updated:  7/23/2015
Oregon Health and Science University
mi
from
Portland, OR
Xanthohumol and Metabolic Syndrome
Xanthohumol and Metabolic Syndrome
Status: Enrolling
Updated: 7/23/2015
Oregon Health and Science University
mi
from
Portland, OR
Click here to add this to my saved trials
Encouraging Calcium Absorption and Bone Formation During Early Puberty
Optimization of Calcium Absorption and Bone Formation During Early Puberty
Status: Enrolling
Updated:  7/23/2015
Children's Nutrition Research Center, Baylor College of Medicine
mi
from
Houston, TX
Encouraging Calcium Absorption and Bone Formation During Early Puberty
Optimization of Calcium Absorption and Bone Formation During Early Puberty
Status: Enrolling
Updated: 7/23/2015
Children's Nutrition Research Center, Baylor College of Medicine
mi
from
Houston, TX
Click here to add this to my saved trials
Study of Phenoptin to Increase Phenylalanine Tolerance in Phenylketonuric Children on a Phenylalanine-restricted Diet
A Phase 3, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Phenoptin to Increase Phenylalanine Tolerance in Phenylketonuric Children on a Phenylalanine-restricted Diet
Status: Enrolling
Updated:  7/23/2015
Clinical Research Facility
mi
from
Los Angeles, CA
Study of Phenoptin to Increase Phenylalanine Tolerance in Phenylketonuric Children on a Phenylalanine-restricted Diet
A Phase 3, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Phenoptin to Increase Phenylalanine Tolerance in Phenylketonuric Children on a Phenylalanine-restricted Diet
Status: Enrolling
Updated: 7/23/2015
Clinical Research Facility
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Study of Phenoptin to Increase Phenylalanine Tolerance in Phenylketonuric Children on a Phenylalanine-restricted Diet
A Phase 3, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Phenoptin to Increase Phenylalanine Tolerance in Phenylketonuric Children on a Phenylalanine-restricted Diet
Status: Enrolling
Updated:  7/23/2015
Clinical Research Facility
mi
from
Oakland, CA
Study of Phenoptin to Increase Phenylalanine Tolerance in Phenylketonuric Children on a Phenylalanine-restricted Diet
A Phase 3, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Phenoptin to Increase Phenylalanine Tolerance in Phenylketonuric Children on a Phenylalanine-restricted Diet
Status: Enrolling
Updated: 7/23/2015
Clinical Research Facility
mi
from
Oakland, CA
Click here to add this to my saved trials
Study of Phenoptin to Increase Phenylalanine Tolerance in Phenylketonuric Children on a Phenylalanine-restricted Diet
A Phase 3, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Phenoptin to Increase Phenylalanine Tolerance in Phenylketonuric Children on a Phenylalanine-restricted Diet
Status: Enrolling
Updated:  7/23/2015
Clinical Research Facility
mi
from
Sacramento, CA
Study of Phenoptin to Increase Phenylalanine Tolerance in Phenylketonuric Children on a Phenylalanine-restricted Diet
A Phase 3, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Phenoptin to Increase Phenylalanine Tolerance in Phenylketonuric Children on a Phenylalanine-restricted Diet
Status: Enrolling
Updated: 7/23/2015
Clinical Research Facility
mi
from
Sacramento, CA
Click here to add this to my saved trials
Study of Phenoptin to Increase Phenylalanine Tolerance in Phenylketonuric Children on a Phenylalanine-restricted Diet
A Phase 3, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Phenoptin to Increase Phenylalanine Tolerance in Phenylketonuric Children on a Phenylalanine-restricted Diet
Status: Enrolling
Updated:  7/23/2015
Clinical Research Facility
mi
from
San Jose, CA
Study of Phenoptin to Increase Phenylalanine Tolerance in Phenylketonuric Children on a Phenylalanine-restricted Diet
A Phase 3, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Phenoptin to Increase Phenylalanine Tolerance in Phenylketonuric Children on a Phenylalanine-restricted Diet
Status: Enrolling
Updated: 7/23/2015
Clinical Research Facility
mi
from
San Jose, CA
Click here to add this to my saved trials
Study of Phenoptin to Increase Phenylalanine Tolerance in Phenylketonuric Children on a Phenylalanine-restricted Diet
A Phase 3, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Phenoptin to Increase Phenylalanine Tolerance in Phenylketonuric Children on a Phenylalanine-restricted Diet
Status: Enrolling
Updated:  7/23/2015
Clinical Research Facility
mi
from
Chicago, IL
Study of Phenoptin to Increase Phenylalanine Tolerance in Phenylketonuric Children on a Phenylalanine-restricted Diet
A Phase 3, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Phenoptin to Increase Phenylalanine Tolerance in Phenylketonuric Children on a Phenylalanine-restricted Diet
Status: Enrolling
Updated: 7/23/2015
Clinical Research Facility
mi
from
Chicago, IL
Click here to add this to my saved trials
Study of Phenoptin to Increase Phenylalanine Tolerance in Phenylketonuric Children on a Phenylalanine-restricted Diet
A Phase 3, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Phenoptin to Increase Phenylalanine Tolerance in Phenylketonuric Children on a Phenylalanine-restricted Diet
Status: Enrolling
Updated:  7/23/2015
Clinical Research Facility
mi
from
Boston, MA
Study of Phenoptin to Increase Phenylalanine Tolerance in Phenylketonuric Children on a Phenylalanine-restricted Diet
A Phase 3, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Phenoptin to Increase Phenylalanine Tolerance in Phenylketonuric Children on a Phenylalanine-restricted Diet
Status: Enrolling
Updated: 7/23/2015
Clinical Research Facility
mi
from
Boston, MA
Click here to add this to my saved trials
Study of Phenoptin to Increase Phenylalanine Tolerance in Phenylketonuric Children on a Phenylalanine-restricted Diet
A Phase 3, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Phenoptin to Increase Phenylalanine Tolerance in Phenylketonuric Children on a Phenylalanine-restricted Diet
Status: Enrolling
Updated:  7/23/2015
Clinical Research Facility
mi
from
Minneapolis, MN
Study of Phenoptin to Increase Phenylalanine Tolerance in Phenylketonuric Children on a Phenylalanine-restricted Diet
A Phase 3, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Phenoptin to Increase Phenylalanine Tolerance in Phenylketonuric Children on a Phenylalanine-restricted Diet
Status: Enrolling
Updated: 7/23/2015
Clinical Research Facility
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Study of Phenoptin to Increase Phenylalanine Tolerance in Phenylketonuric Children on a Phenylalanine-restricted Diet
A Phase 3, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Phenoptin to Increase Phenylalanine Tolerance in Phenylketonuric Children on a Phenylalanine-restricted Diet
Status: Enrolling
Updated:  7/23/2015
Clinical Research Facility
mi
from
St. Louis, MO
Study of Phenoptin to Increase Phenylalanine Tolerance in Phenylketonuric Children on a Phenylalanine-restricted Diet
A Phase 3, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Phenoptin to Increase Phenylalanine Tolerance in Phenylketonuric Children on a Phenylalanine-restricted Diet
Status: Enrolling
Updated: 7/23/2015
Clinical Research Facility
mi
from
St. Louis, MO
Click here to add this to my saved trials
Study of Phenoptin to Increase Phenylalanine Tolerance in Phenylketonuric Children on a Phenylalanine-restricted Diet
A Phase 3, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Phenoptin to Increase Phenylalanine Tolerance in Phenylketonuric Children on a Phenylalanine-restricted Diet
Status: Enrolling
Updated:  7/23/2015
Clinical Research Facility
mi
from
Salt Lake City, UT
Study of Phenoptin to Increase Phenylalanine Tolerance in Phenylketonuric Children on a Phenylalanine-restricted Diet
A Phase 3, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Phenoptin to Increase Phenylalanine Tolerance in Phenylketonuric Children on a Phenylalanine-restricted Diet
Status: Enrolling
Updated: 7/23/2015
Clinical Research Facility
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Safety and Tolerability Study of rAvPAL-PEG to Treat Phenylketonuria
A Phase I, Open-Label, Dose-Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single, Subcutaneous Doses of rAvPAL-PEG in Subjects With Phenylketonuria
Status: Enrolling
Updated:  7/23/2015
Children's Memorial Hospital
mi
from
Chicago, IL
Safety and Tolerability Study of rAvPAL-PEG to Treat Phenylketonuria
A Phase I, Open-Label, Dose-Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single, Subcutaneous Doses of rAvPAL-PEG in Subjects With Phenylketonuria
Status: Enrolling
Updated: 7/23/2015
Children's Memorial Hospital
mi
from
Chicago, IL
Click here to add this to my saved trials
Safety and Tolerability Study of rAvPAL-PEG to Treat Phenylketonuria
A Phase I, Open-Label, Dose-Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single, Subcutaneous Doses of rAvPAL-PEG in Subjects With Phenylketonuria
Status: Enrolling
Updated:  7/23/2015
University of Minnesota Medical Center, Fairview
mi
from
Minneapolis, MN
Safety and Tolerability Study of rAvPAL-PEG to Treat Phenylketonuria
A Phase I, Open-Label, Dose-Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single, Subcutaneous Doses of rAvPAL-PEG in Subjects With Phenylketonuria
Status: Enrolling
Updated: 7/23/2015
University of Minnesota Medical Center, Fairview
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Safety and Tolerability Study of rAvPAL-PEG to Treat Phenylketonuria
A Phase I, Open-Label, Dose-Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single, Subcutaneous Doses of rAvPAL-PEG in Subjects With Phenylketonuria
Status: Enrolling
Updated:  7/23/2015
Washington University Center for Applied Research Sciences
mi
from
St. Louis, MO
Safety and Tolerability Study of rAvPAL-PEG to Treat Phenylketonuria
A Phase I, Open-Label, Dose-Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single, Subcutaneous Doses of rAvPAL-PEG in Subjects With Phenylketonuria
Status: Enrolling
Updated: 7/23/2015
Washington University Center for Applied Research Sciences
mi
from
St. Louis, MO
Click here to add this to my saved trials
Safety and Tolerability Study of rAvPAL-PEG to Treat Phenylketonuria
A Phase I, Open-Label, Dose-Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single, Subcutaneous Doses of rAvPAL-PEG in Subjects With Phenylketonuria
Status: Enrolling
Updated:  7/23/2015
Mount Sinai Hospital
mi
from
New York, NY
Safety and Tolerability Study of rAvPAL-PEG to Treat Phenylketonuria
A Phase I, Open-Label, Dose-Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single, Subcutaneous Doses of rAvPAL-PEG in Subjects With Phenylketonuria
Status: Enrolling
Updated: 7/23/2015
Mount Sinai Hospital
mi
from
New York, NY
Click here to add this to my saved trials
Safety and Tolerability Study of rAvPAL-PEG to Treat Phenylketonuria
A Phase I, Open-Label, Dose-Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single, Subcutaneous Doses of rAvPAL-PEG in Subjects With Phenylketonuria
Status: Enrolling
Updated:  7/23/2015
Oregon Health and Science University
mi
from
Portland, OR
Safety and Tolerability Study of rAvPAL-PEG to Treat Phenylketonuria
A Phase I, Open-Label, Dose-Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single, Subcutaneous Doses of rAvPAL-PEG in Subjects With Phenylketonuria
Status: Enrolling
Updated: 7/23/2015
Oregon Health and Science University
mi
from
Portland, OR
Click here to add this to my saved trials
Safety and Tolerability Study of rAvPAL-PEG to Treat Phenylketonuria
A Phase I, Open-Label, Dose-Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single, Subcutaneous Doses of rAvPAL-PEG in Subjects With Phenylketonuria
Status: Enrolling
Updated:  7/23/2015
University of Pittsburgh
mi
from
Pittsburgh, PA
Safety and Tolerability Study of rAvPAL-PEG to Treat Phenylketonuria
A Phase I, Open-Label, Dose-Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single, Subcutaneous Doses of rAvPAL-PEG in Subjects With Phenylketonuria
Status: Enrolling
Updated: 7/23/2015
University of Pittsburgh
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Safety and Tolerability Study of rAvPAL-PEG to Treat Phenylketonuria
A Phase I, Open-Label, Dose-Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single, Subcutaneous Doses of rAvPAL-PEG in Subjects With Phenylketonuria
Status: Enrolling
Updated:  7/23/2015
University Of Utah Hospital
mi
from
Salt Lake City, UT
Safety and Tolerability Study of rAvPAL-PEG to Treat Phenylketonuria
A Phase I, Open-Label, Dose-Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single, Subcutaneous Doses of rAvPAL-PEG in Subjects With Phenylketonuria
Status: Enrolling
Updated: 7/23/2015
University Of Utah Hospital
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Safety and Tolerability Study of rAvPAL-PEG to Treat Phenylketonuria
A Phase I, Open-Label, Dose-Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single, Subcutaneous Doses of rAvPAL-PEG in Subjects With Phenylketonuria
Status: Enrolling
Updated:  7/23/2015
University of Wisconsin
mi
from
Madison, WI
Safety and Tolerability Study of rAvPAL-PEG to Treat Phenylketonuria
A Phase I, Open-Label, Dose-Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single, Subcutaneous Doses of rAvPAL-PEG in Subjects With Phenylketonuria
Status: Enrolling
Updated: 7/23/2015
University of Wisconsin
mi
from
Madison, WI
Click here to add this to my saved trials
Prediction of Severity of Liver Disease by a 13C Octanoate Breath Test (OBT)
Prediction of Severity of Liver Disease in Patients With Suspected Nonalcoholic Fatty Liver Disease (NAFLD) by 13C Octanoate Breath Test (OBT)
Status: Enrolling
Updated:  7/27/2015
Baylor College of Medicine
mi
from
Houston, TX
Prediction of Severity of Liver Disease by a 13C Octanoate Breath Test (OBT)
Prediction of Severity of Liver Disease in Patients With Suspected Nonalcoholic Fatty Liver Disease (NAFLD) by 13C Octanoate Breath Test (OBT)
Status: Enrolling
Updated: 7/27/2015
Baylor College of Medicine
mi
from
Houston, TX
Click here to add this to my saved trials
Prediction of Severity of Liver Disease by a 13C Octanoate Breath Test (OBT)
Prediction of Severity of Liver Disease in Patients With Suspected Nonalcoholic Fatty Liver Disease (NAFLD) by 13C Octanoate Breath Test (OBT)
Status: Enrolling
Updated:  7/27/2015
Virginia Commonwealth University
mi
from
Richmond, VA
Prediction of Severity of Liver Disease by a 13C Octanoate Breath Test (OBT)
Prediction of Severity of Liver Disease in Patients With Suspected Nonalcoholic Fatty Liver Disease (NAFLD) by 13C Octanoate Breath Test (OBT)
Status: Enrolling
Updated: 7/27/2015
Virginia Commonwealth University
mi
from
Richmond, VA
Click here to add this to my saved trials
Dietary Interventions in Prediabetes
The Effects of Dietary Supplementation on Hepatic Insulin Action and Glucose Tolerance in Pre-diabetes
Status: Enrolling
Updated:  7/27/2015
The Mayo Clinic
mi
from
Rochester, MN
Dietary Interventions in Prediabetes
The Effects of Dietary Supplementation on Hepatic Insulin Action and Glucose Tolerance in Pre-diabetes
Status: Enrolling
Updated: 7/27/2015
The Mayo Clinic
mi
from
Rochester, MN
Click here to add this to my saved trials
Wolman/CESD Natural History Chart Review and Longitudinal Follow-Up
A Historical Chart Review and Longitudinal Follow-Up of Identified Patients With Wolman Disease or Cholesteryl Ester Storage Disease, Lysosomal Acid Lipase Deficiency
Status: Enrolling
Updated:  7/27/2015
Cincinnati Children's Hospital Medical Center
mi
from
Cincinnati, OH
Wolman/CESD Natural History Chart Review and Longitudinal Follow-Up
A Historical Chart Review and Longitudinal Follow-Up of Identified Patients With Wolman Disease or Cholesteryl Ester Storage Disease, Lysosomal Acid Lipase Deficiency
Status: Enrolling
Updated: 7/27/2015
Cincinnati Children's Hospital Medical Center
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Pilot Study To Assess CAT-2003 in Patients With Severe Hypertriglyceridemia
A Phase 2 Pilot Study to Assess the Safety and Efficacy of CAT-2003 in Patients With Severe Hypertriglyceridemia
Status: Enrolling
Updated:  7/27/2015
Clinical Research Facility
mi
from
Indianapolis, IN
Pilot Study To Assess CAT-2003 in Patients With Severe Hypertriglyceridemia
A Phase 2 Pilot Study to Assess the Safety and Efficacy of CAT-2003 in Patients With Severe Hypertriglyceridemia
Status: Enrolling
Updated: 7/27/2015
Clinical Research Facility
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Pilot Study To Assess CAT-2003 in Patients With Severe Hypertriglyceridemia
A Phase 2 Pilot Study to Assess the Safety and Efficacy of CAT-2003 in Patients With Severe Hypertriglyceridemia
Status: Enrolling
Updated:  7/27/2015
Clinical Research Facility
mi
from
Auburn, ME
Pilot Study To Assess CAT-2003 in Patients With Severe Hypertriglyceridemia
A Phase 2 Pilot Study to Assess the Safety and Efficacy of CAT-2003 in Patients With Severe Hypertriglyceridemia
Status: Enrolling
Updated: 7/27/2015
Clinical Research Facility
mi
from
Auburn, ME
Click here to add this to my saved trials
Pilot Study To Assess CAT-2003 in Patients With Severe Hypertriglyceridemia
A Phase 2 Pilot Study to Assess the Safety and Efficacy of CAT-2003 in Patients With Severe Hypertriglyceridemia
Status: Enrolling
Updated:  7/27/2015
Clinical Research Facility
mi
from
Cincinnati, OH
Pilot Study To Assess CAT-2003 in Patients With Severe Hypertriglyceridemia
A Phase 2 Pilot Study to Assess the Safety and Efficacy of CAT-2003 in Patients With Severe Hypertriglyceridemia
Status: Enrolling
Updated: 7/27/2015
Clinical Research Facility
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Pilot Study To Assess CAT-2003 in Patients With Severe Hypertriglyceridemia
A Phase 2 Pilot Study to Assess the Safety and Efficacy of CAT-2003 in Patients With Severe Hypertriglyceridemia
Status: Enrolling
Updated:  7/27/2015
Clinical Research Facility
mi
from
Miami, FL
Pilot Study To Assess CAT-2003 in Patients With Severe Hypertriglyceridemia
A Phase 2 Pilot Study to Assess the Safety and Efficacy of CAT-2003 in Patients With Severe Hypertriglyceridemia
Status: Enrolling
Updated: 7/27/2015
Clinical Research Facility
mi
from
Miami, FL
Click here to add this to my saved trials
Diagnosis of Mucopolysaccharidosis Disorders in Patients Presenting With Bilateral Hip Disease
Diagnosis of Mucopolysaccharidosis Disorders in Patients Presenting With Bilateral Hip Disease
Status: Enrolling
Updated:  7/31/2015
Children's Hospitals and Clinics of Minnesota
mi
from
Minneapolis, MN
Diagnosis of Mucopolysaccharidosis Disorders in Patients Presenting With Bilateral Hip Disease
Diagnosis of Mucopolysaccharidosis Disorders in Patients Presenting With Bilateral Hip Disease
Status: Enrolling
Updated: 7/31/2015
Children's Hospitals and Clinics of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Diagnosis of Mucopolysaccharidosis Disorders in Patients Presenting With Bilateral Hip Disease
Diagnosis of Mucopolysaccharidosis Disorders in Patients Presenting With Bilateral Hip Disease
Status: Enrolling
Updated:  7/31/2015
Gillette Children's Specialty Healthcare
mi
from
St Paul, MN
Diagnosis of Mucopolysaccharidosis Disorders in Patients Presenting With Bilateral Hip Disease
Diagnosis of Mucopolysaccharidosis Disorders in Patients Presenting With Bilateral Hip Disease
Status: Enrolling
Updated: 7/31/2015
Gillette Children's Specialty Healthcare
mi
from
St Paul, MN
Click here to add this to my saved trials
Metabolic Syndrome Feasibility Study
Prognostic Indicators for Metabolic Syndrome as Provided by the EPIC ClearView
Status: Enrolling
Updated:  8/3/2015
EPIC Research and Diagnostics
mi
from
Scottsdale, AZ
Metabolic Syndrome Feasibility Study
Prognostic Indicators for Metabolic Syndrome as Provided by the EPIC ClearView
Status: Enrolling
Updated: 8/3/2015
EPIC Research and Diagnostics
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Metabolic Syndrome Feasibility Study
Prognostic Indicators for Metabolic Syndrome as Provided by the EPIC ClearView
Status: Enrolling
Updated:  8/3/2015
Integrated Health Institute, LLC
mi
from
Scottsdale, AZ
Metabolic Syndrome Feasibility Study
Prognostic Indicators for Metabolic Syndrome as Provided by the EPIC ClearView
Status: Enrolling
Updated: 8/3/2015
Integrated Health Institute, LLC
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Mitochondria and Metabolic Syndrome in a Southern California Chinese Cohort
Diffuse Optical Spectroscopy Measurement Technique is Helping Develop More Effective Diagnostic Tools and Therapeutic Regimes for Diabetes, Metabolic Syndrome and Other Mitochondrial Diseases Some Time in the Future
Status: Enrolling
Updated:  8/5/2015
Beckman Laser Institute Medical clinic
mi
from
Irvine, CA
Mitochondria and Metabolic Syndrome in a Southern California Chinese Cohort
Diffuse Optical Spectroscopy Measurement Technique is Helping Develop More Effective Diagnostic Tools and Therapeutic Regimes for Diabetes, Metabolic Syndrome and Other Mitochondrial Diseases Some Time in the Future
Status: Enrolling
Updated: 8/5/2015
Beckman Laser Institute Medical clinic
mi
from
Irvine, CA
Click here to add this to my saved trials
Vascular Reactivity in Metabolic Syndrome and Diabetic Patients Using Diffuse Optical Spectroscopy
Diffuse Optical Spectroscopy Measure Microvascular Changes in Metabolic Syndrome and Diabetes Mellitus in Order to Assess Cardiovascular Disease Risk.
Status: Enrolling
Updated:  8/5/2015
Beckman Laser Institute Medical clinic
mi
from
Irvine, CA
Vascular Reactivity in Metabolic Syndrome and Diabetic Patients Using Diffuse Optical Spectroscopy
Diffuse Optical Spectroscopy Measure Microvascular Changes in Metabolic Syndrome and Diabetes Mellitus in Order to Assess Cardiovascular Disease Risk.
Status: Enrolling
Updated: 8/5/2015
Beckman Laser Institute Medical clinic
mi
from
Irvine, CA
Click here to add this to my saved trials
Effect of Testosterone Gel Replacement on Fat Mass in Males With Low Testosterone Levels and Diabetes
Effect of Androgel on Total and Regional Adipose Tissue and Lean Body Mass in Type 2 Diabetic Patients With Hypogonadism
Status: Enrolling
Updated:  8/6/2015
'Diabetes Center of the Southwest
mi
from
Midland, TX
Effect of Testosterone Gel Replacement on Fat Mass in Males With Low Testosterone Levels and Diabetes
Effect of Androgel on Total and Regional Adipose Tissue and Lean Body Mass in Type 2 Diabetic Patients With Hypogonadism
Status: Enrolling
Updated: 8/6/2015
'Diabetes Center of the Southwest
mi
from
Midland, TX
Click here to add this to my saved trials
Physical Inactivity and Insulin Resistance in Skeletal Muscle.
Physical Inactivity and Insulin Resistance in Skeletal Muscle.
Status: Enrolling
Updated:  8/10/2015
Harry S. Truman Memorial Veterans' Hospital
mi
from
Columbia, MO
Physical Inactivity and Insulin Resistance in Skeletal Muscle.
Physical Inactivity and Insulin Resistance in Skeletal Muscle.
Status: Enrolling
Updated: 8/10/2015
Harry S. Truman Memorial Veterans' Hospital
mi
from
Columbia, MO
Click here to add this to my saved trials
Screening an Orthopedic Population for Mildly-affected Individuals With Morquio Syndrome A and Maroteaux-Lamy Syndrome
Screening an Orthopedic Population for Mildly-affected Individuals With Morquio Syndrome Type A and Maroteaux-Lamy Syndrome
Status: Enrolling
Updated:  8/10/2015
Greenwood Genetic Center
mi
from
Greenville, SC
Screening an Orthopedic Population for Mildly-affected Individuals With Morquio Syndrome A and Maroteaux-Lamy Syndrome
Screening an Orthopedic Population for Mildly-affected Individuals With Morquio Syndrome Type A and Maroteaux-Lamy Syndrome
Status: Enrolling
Updated: 8/10/2015
Greenwood Genetic Center
mi
from
Greenville, SC
Click here to add this to my saved trials
MGA031, Sirolimus and Tacrolimus in Islet Transplantation
hOKT3γ1 (Ala-Ala), Sirolimus and Low Dose Tacrolimus Therapy in Type 1 Diabetic Islet Allograft Recipients
Status: Enrolling
Updated:  8/11/2015
Univ of Minnesota
mi
from
Minneapolis, MN
MGA031, Sirolimus and Tacrolimus in Islet Transplantation
hOKT3γ1 (Ala-Ala), Sirolimus and Low Dose Tacrolimus Therapy in Type 1 Diabetic Islet Allograft Recipients
Status: Enrolling
Updated: 8/11/2015
Univ of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Interventional Cryotherapy for the Eradication of Benign Airway Disease ("ICE the BAD")
Assessment of the Safety, Side Effects and Efficacy of Interventional Cryotherapy for the Eradication of Benign Airway Disease("ICE THE BAD")
Status: Enrolling
Updated:  8/11/2015
Cleveland Clinic Foundation
mi
from
Cleveland, OH
Interventional Cryotherapy for the Eradication of Benign Airway Disease ("ICE the BAD")
Assessment of the Safety, Side Effects and Efficacy of Interventional Cryotherapy for the Eradication of Benign Airway Disease("ICE THE BAD")
Status: Enrolling
Updated: 8/11/2015
Cleveland Clinic Foundation
mi
from
Cleveland, OH
Click here to add this to my saved trials
Evaluation of Pancreatic Pseudocyst Drainage With a Metal Stent
Prospective Evaluation of the Clinical Utility of Pseudocyst Drainage With Metal Stent
Status: Enrolling
Updated:  8/21/2015
Shands UF Endoscopy
mi
from
Gainesville, FL
Evaluation of Pancreatic Pseudocyst Drainage With a Metal Stent
Prospective Evaluation of the Clinical Utility of Pseudocyst Drainage With Metal Stent
Status: Enrolling
Updated: 8/21/2015
Shands UF Endoscopy
mi
from
Gainesville, FL
Click here to add this to my saved trials
The Effect on Androxal Versus Androgel on Morning Testosterone in Men With Secondary Hypogonadism (Low Testosterone)
A Randomized, Single Blind, Multi-Center Phase II Study to Evaluate the Effect of Three Different Doses of Androxal and AndroGel on 24-Hour Luteinizing Hormone and Testosterone in Normal Healthy Men
Status: Enrolling
Updated:  8/21/2015
Centex Research
mi
from
Houston, TX
The Effect on Androxal Versus Androgel on Morning Testosterone in Men With Secondary Hypogonadism (Low Testosterone)
A Randomized, Single Blind, Multi-Center Phase II Study to Evaluate the Effect of Three Different Doses of Androxal and AndroGel on 24-Hour Luteinizing Hormone and Testosterone in Normal Healthy Men
Status: Enrolling
Updated: 8/21/2015
Centex Research
mi
from
Houston, TX
Click here to add this to my saved trials
The Effect on Androxal Versus Androgel on Morning Testosterone in Men With Secondary Hypogonadism (Low Testosterone)
A Randomized, Single Blind, Multi-Center Phase II Study to Evaluate the Effect of Three Different Doses of Androxal and AndroGel on 24-Hour Luteinizing Hormone and Testosterone in Normal Healthy Men
Status: Enrolling
Updated:  8/21/2015
Cetero Research
mi
from
San Antonio, TX
The Effect on Androxal Versus Androgel on Morning Testosterone in Men With Secondary Hypogonadism (Low Testosterone)
A Randomized, Single Blind, Multi-Center Phase II Study to Evaluate the Effect of Three Different Doses of Androxal and AndroGel on 24-Hour Luteinizing Hormone and Testosterone in Normal Healthy Men
Status: Enrolling
Updated: 8/21/2015
Cetero Research
mi
from
San Antonio, TX
Click here to add this to my saved trials
Trial of Aromatase Inhibition in Lymphangioleiomyomatosis
A TRIAL OF LETROZOLE IN PULMONARY LYMPHANGIOLEIOMYOMATOSIS
Status: Enrolling
Updated:  8/24/2015
University of Cincinnati
mi
from
Cincinnati, OH
Trial of Aromatase Inhibition in Lymphangioleiomyomatosis
A TRIAL OF LETROZOLE IN PULMONARY LYMPHANGIOLEIOMYOMATOSIS
Status: Enrolling
Updated: 8/24/2015
University of Cincinnati
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Trial of Aromatase Inhibition in Lymphangioleiomyomatosis
A TRIAL OF LETROZOLE IN PULMONARY LYMPHANGIOLEIOMYOMATOSIS
Status: Enrolling
Updated:  8/24/2015
Stanford Univ Med Ctr
mi
from
Stanford, CA
Trial of Aromatase Inhibition in Lymphangioleiomyomatosis
A TRIAL OF LETROZOLE IN PULMONARY LYMPHANGIOLEIOMYOMATOSIS
Status: Enrolling
Updated: 8/24/2015
Stanford Univ Med Ctr
mi
from
Stanford, CA
Click here to add this to my saved trials
Trial of Aromatase Inhibition in Lymphangioleiomyomatosis
A TRIAL OF LETROZOLE IN PULMONARY LYMPHANGIOLEIOMYOMATOSIS
Status: Enrolling
Updated:  8/24/2015
Mayo Clinic
mi
from
Jacksonville, FL
Trial of Aromatase Inhibition in Lymphangioleiomyomatosis
A TRIAL OF LETROZOLE IN PULMONARY LYMPHANGIOLEIOMYOMATOSIS
Status: Enrolling
Updated: 8/24/2015
Mayo Clinic
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Trial of Aromatase Inhibition in Lymphangioleiomyomatosis
A TRIAL OF LETROZOLE IN PULMONARY LYMPHANGIOLEIOMYOMATOSIS
Status: Enrolling
Updated:  8/24/2015
University of Miami
mi
from
Miami, FL
Trial of Aromatase Inhibition in Lymphangioleiomyomatosis
A TRIAL OF LETROZOLE IN PULMONARY LYMPHANGIOLEIOMYOMATOSIS
Status: Enrolling
Updated: 8/24/2015
University of Miami
mi
from
Miami, FL
Click here to add this to my saved trials